ADVANCELL’s technology has potential applications for the nasal administration of bioactive molecules such as vaccines, peptides or genetic material, as has been described in multiple scientific papers published by a research team led by professor María José Alonso of the University of Santiago de Compostela.
Several in-vivo studies have shown that the therapeutic effects or antibody levels are enhanced after such drugs are formulated in its nanosystems.